CognitMarket market news, portfolio research, and investor insights

S&P Global Ratings has upgraded RTX Corp (RTX) to 'A-' from 'BBB+' with a stable outlook, citing robust aerospace and defense demand and disciplined balance-sheet repair [1].

Key drivers:

• Projected adjusted debt to EBITDA below 2.5x and FFO to debt above 30%.
• Management on track to pay down remaining $2.9B debt from late 2023 share repurchase.
• Expected free operating cash flow over $9B this year, with further expansion in 2027.
• Strong operational momentum in commercial aerospace (Collins Aerospace, Pratt & Whitney) and defense (Raytheon backlog at $130B, 12-month book-to-bill 2.9x).

This upgrade reflects improved credit quality and operational strength for the defense and aerospace giant.

Nvidia's board has reportedly approached Arm CEO Rene Haas as part of its search for a potential successor to Jensen Huang [1]. This development follows recent news of Huang's resignation amid an intelligence probe (Post 3, Post 4, Post 17).

Key points:

• Succession Planning: The reported outreach suggests active succession planning is underway at Nvidia.
• Potential Impact: A change in leadership at Nvidia, a dominant force in AI, could significantly influence market sentiment and the company's strategic direction.
• Context: This comes after previous reports of Huang's resignation and an ongoing intelligence probe, creating uncertainty around the company's top leadership (Post 3, Post 4, Post 17).

ams OSRAM (AMS.DE) shares fell 5.72% in pre-market trading after Q3 2026 earnings, despite reporting a modest revenue beat of EUR 829M vs. EUR 817.73M forecast [1].

Investors focused on:

• 3% year-on-year revenue decline.
• 19% drop in adjusted EBITDA.
• Cautious near-term guidance, overshadowing core semiconductor portfolio growth and a strengthened balance sheet post-divestments [1].

Global Payments (GPN) shares fell 9% after private equity firms CD&R and GTCR abandoned discussions for a potential acquisition. The buyout consortium explored a deal for weeks but failed to advance due to complexities and challenging financing conditions for a transaction of this scale (~$26.4B market cap). The news removes a significant potential catalyst for GPN shares [1].

Jensen Huang has resigned as Nvidia's President and CEO, ending his 33-year tenure. CFO Colette Kress is appointed interim CEO [1] [2]. The resignation comes as Senator Schumer continues to seek answers from Huang and Nvidia regarding potential national security risks and alleged links to Chinese intelligence [3].

Meanwhile, speculation is growing about a potential partnership between Huang and Elon Musk, with Musk publicly expressing interest in hiring Huang. SpaceX shares rose ~4% on the news, as investors consider the implications for AI infrastructure and semiconductor manufacturing [1].

Reports now explicitly link China's Ministry of State Security (MSS) to alleged efforts to gather intelligence on Nvidia CEO Jensen Huang [1]. This follows earlier reports of a foreign intelligence probe.

Key details:

• MSS allegedly recruited businesswoman Alice Huang (no relation) to gather information [1].
• Jensen Huang has admitted to an affair, though it's unclear if sensitive information was shared [1].
• The MSS's prominence has grown with Beijing's focus on national security [1].

This development adds specificity to ongoing geopolitical concerns surrounding Nvidia and its leadership.

Semiconductor equipment manufacturers like Applied Materials (+6.45%), Lam Research (+6.87%), and KLA (+5.68%) are rallying today, bouncing back after a tough month. Analysts note that underlying fundamentals remain strong, with demand potentially outstripping the industry's ability to ship [1].

Key points:

• LRCX identified as a strong candidate based on data.
• ASML highlighted as a valuation-conscious alternative with high FCF yield.
• Risks include shipment delays, China export curbs, and the need for sustained cycle delivery [1].

Wells Fargo has designated Annexon, Inc. (ANNX) as its top pick in the biotechnology sector, maintaining an Overweight rating and a $27.00 price target. The firm highlights a compelling setup ahead of a critical Q4 2026 data readout for its ARCHER II trial in generalized myasthenia gravis (GA) [1].

Key points:

• Wells Fargo assigns a 55% probability of success for a positive Month-15 outcome in the ARCHER II trial, projecting a potential 3-4x stock re-rating [1].
• The company's tanruprubart Biologics License Application is on track for Q4 2026 submission [1].
• Annexon ended Q3 2026 with $213M in cash, with management reiterating financial runway into 2028 [1].

Delek US Holdings (DK) shares climbed 4% after Freedom Broker upgraded the independent refiner to Buy from Hold, raising the price target to $88 from $86 [1].

Key drivers cited:

• Strong Q3 Performance: Nearly doubled adjusted net income to $843M ($13.55/share) due to surging crack spreads and full refinery utilization [1].
• Balance Sheet Improvement: Reduced net debt by $506.4M sequentially, leading to a net cash position for the parent entity [1].
• Shareholder Returns: Increased quarterly dividend by 18% to $0.30/share and authorized up to $100M in Q4 share buybacks [1].

The upgrade suggests significant upside potential following a recent 20% pullback, with analysts highlighting durable downside support from a strengthened balance sheet and heightened distributions [1].

China Automotive Systems (CAAS) announced record electric power steering (EPS) unit sales for Q3 2026, with 567,314 units sold, a 40.1% increase year-over-year. The company also approved a new share repurchase program of up to $5 million, with shares to be bought at prices not exceeding $5.50 over the next 12 months [1].

Key points:

• Q3 EPS unit sales up 40.1% YoY.
• Nine-month EPS sales up 32.7% YoY.
• $5M share buyback authorized, representing a significant return to shareholders for the small-cap auto parts supplier.